Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
- 15 January 2008
- journal article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 197 (2) , 117-123
- https://doi.org/10.1007/s00430-008-0074-5
Abstract
A vaccine consisting of rhesus cytomegalovirus (RhCMV) pp65-2, gB and IE1 expressed via modified vaccinia Ankara (MVA) was evaluated in rhesus macaques with or without prior priming with expression plasmids for the same antigens. Following two MVA treatments, comparable levels of anti-gB, pp65-2 and neutralizing antibody responses, and pp65-2- and IE1-specific cellular immune responses were detected in both vaccinated groups. Similar reductions in plasma peak viral loads were observed in these groups compared to untreated controls. This study demonstrates the immunogenicity and protective efficacy of rMVA-based RhCMV subunit vaccines in a primate host and warrants further investigation to improve the efficacy of subunit vaccines against CMV.Keywords
This publication has 27 references indexed in Scilit:
- Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVAVirology, 2007
- Primate betaherpesvirusesPublished by Cambridge University Press (CUP) ,2007
- Immunogenicity and Protective Efficacy of DNA Vaccines Expressing Rhesus Cytomegalovirus Glycoprotein B, Phosphoprotein 65-2, and Viral Interleukin-10 in Rhesus MacaquesJournal of Virology, 2007
- Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1Vaccine, 2006
- Protection against Congenital Cytomegalovirus Infection and Disease in Guinea Pigs, Conferred by a Purified Recombinant Glycoprotein B VaccineThe Journal of Infectious Diseases, 2004
- Preconception Vaccination with a Glycoprotein B (gB) DNA Vaccine Protects against Cytomegalovirus (CMV) Transmission in the Guinea Pig Model of Congenital CMV InfectionThe Journal of Infectious Diseases, 2003
- Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaquesJournal of General Virology, 2003
- A Recombinant Rhesus Cytomegalovirus Expressing Enhanced Green Fluorescent Protein Retains the Wild-Type Phenotype and Pathogenicity in Fetal MacaquesJournal of Virology, 2002
- Cytomegalovirus and Simian Immunodeficiency Virus CoinfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981